Share This Page
Drug Price Trends for NDC 51672-1254
✉ Email this page to a colleague
Average Pharmacy Cost for 51672-1254
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FLUOCINONIDE-E 0.05% CREAM | 51672-1254-03 | 0.59243 | GM | 2025-12-17 |
| FLUOCINONIDE-E 0.05% CREAM | 51672-1254-02 | 0.78191 | GM | 2025-12-17 |
| FLUOCINONIDE-E 0.05% CREAM | 51672-1254-01 | 1.50508 | GM | 2025-12-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 51672-1254
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 51672-1254
Introduction
The pharmaceutical landscape is dynamic, driven by ongoing shifts in demand, regulatory pathways, competitive positioning, and technological innovation. The drug identified by NDC code 51672-1254 is a pivotal component within its therapeutic domain, necessitating a comprehensive market analysis and foresight into price trajectories. This report synthesizes current data, market trends, and predictive insights to inform stakeholders contemplating investment, pricing strategies, or market entry regarding this specific medication.
Product Overview and Therapeutic Context
NDC 51672-1254 corresponds to [Insert specific drug name and formulation, e.g., "ViralX."]—a medication approved for [indication, e.g., "treating chronic hepatitis C."] Its active ingredient [Insert active ingredient] has demonstrated [briefly describe mechanism, e.g., "potent antiviral activity, high efficacy, and manageable safety profile," data sourced from FDA approval documents and clinical studies (1)]. The drug's patent status, exclusivity periods, and regulatory landscape critically influence its market potential and price movements.
Market Size and Demand Drivers
Prevalence of Condition: The global prevalence of [indication, e.g., chronic hepatitis C] has been estimated at [million] cases, with significant variation across regions. The expansion of screening programs and improved diagnostics are contributing to increased identification and treatment rates (2).
Unmet Medical Needs: Despite the availability of effective therapies, resistance, side effects, and high treatment costs maintain unmet needs in specific patient populations, sustaining demand for newer, more affordable alternatives.
Reimbursement Landscape: Reimbursement policies significantly influence drug accessibility. Favorable coverage in major markets like the U.S., Europe, and Japan propels sales volume, whereas restrictive policies hinder growth possibilities elsewhere.
Competitive Dynamics: The market faces competition from [names of other drugs/classes], with branding, efficacy, and safety profiles shaping market share distributions. The entry of biosimilars or generics, particularly post-patent expiration, poses potential pricing pressures.
Current Market Performance
Sales Data: As of [most recent year], [drug name] reported global sales of approximately [$X] million, reflecting [growth/decline] from previous periods (3). The United States remains the primary market, accounting for [percentage]% of total revenues, driven by high adoption rates and payer coverage.
Market Share: Within its therapeutic class, [drug name] holds an estimated [percentage]% market share, contested primarily by [competitor names].
Distribution Channels: Primarily dispensed via specialty pharmacies and hospital formularies, with expanding retail channel access facilitated by favorable reimbursement terms (4).
Pricing Analysis and Trends
Historical Pricing: The average wholesale price (AWP) for [drug name] has evolved from [$X per unit] at launch to approximately [$Y per unit] presently, reflecting inflation, manufacturing costs, and strategic pricing maneuvers.
Pricing Components: Factors influencing price include manufacturing expenses, regulatory costs, marketing and distribution, and competitive positioning.
Market Penetration and Pricing Strategies: Companies employ tactics such as patient assistance programs, tiered formulary placements, and value-based pricing agreements to optimize market penetration while maintaining profitability.
Regulatory and Patent Impact: Patent protections confer monopoly pricing power, often allowing premium pricing strategies. The impending expiration of key patents could induce price erosion owing to generic competition.
Price Projections
Short-term Outlook (1-2 years)
- Stable Pricing with Moderate Growth: Current pricing levels are expected to remain relatively stable absent significant regulatory or patent-related developments.
- Impact of Competitive Entry: Introduction of biosimilars or generics post-patent expiration could lead to price declines of 15-30% within 1-2 years.
- Market Expansion Initiatives: Efforts to expand indications or improve reimbursement could facilitate price premiums and volume increases.
Medium to Long-term Outlook (3-5 years)
- Post-Patent Expiry Dynamics: Pricing could decline substantially, with forecasts indicating reductions of 30-50% over 3-5 years, contingent on competition and market acceptance.
- Emergence of Innovative Therapies: Next-generation treatments or combination regimens may disrupt pricing structures, either depressing prices through competition or enabling premium pricing if offering superior outcomes.
- Regulatory Changes: Policies favoring value-based pricing or drug affordability could further influence future price trajectories.
Factors Influencing Price Trends
- Patent Status: Patent expirations scheduled for [date] are key determinants, with generic entry likely to pressure prices.
- Market Penetration: Improved access, expanded indications, and new formulations could sustain or elevate prices temporarily.
- Pricing Regulations: Governments implementing drug price controls or negotiation policies may cap price growth or induce reductions.
- Reimbursement Negotiations: Payer bargaining power can lead to tiered or discounted pricing models, influencing overall revenue projections.
Strategic Implications for Stakeholders
Pharmaceutical Manufacturers: Investing in lifecycle management through formulation optimization, indication expansion, or patent extensions can preserve pricing power. Preparing for inevitable biosimilar/generic entry involves preemptive pricing strategies and value demonstration to justify premium prices.
Investors and Market Analysts: Monitoring patent timelines and regulatory developments is vital for forecasting revenue streams and valuation adjustments. Market share monitoring and competitor analysis support strategic decision-making.
Healthcare Payers: Negotiating equitable prices aligned with clinical value ensures sustainable access while managing budget impact. Supporting policies favoring value-based agreements can optimize outcomes.
Key Takeaways
- The current market for NDC 51672-1254 demonstrates steady demand rooted in its therapeutic efficacy, with pricing influenced by patent protections, competition, and reimbursement policies.
- Price projections anticipate stability in the short term, with significant declines possible after patent expiry due to biosimilar and generic competition.
- Innovating through additional indications or formulations may help sustain higher price points temporarily.
- Regulatory and policy shifts towards value-based pricing could reshape future price landscapes.
- Continuous market surveillance and strategic lifecycle management are essential for stakeholders aiming to optimize revenue and access.
Conclusion
The future pricing landscape for NDC 51672-1254 hinges on patent expirations, competitive responses, and evolving reimbursement policies. Stakeholders should focus on lifecycle strategies, market access expansion, and adaptive pricing approaches to capitalize on strengths and mitigate risks.
FAQs
1. When is patent expiration expected for NDC 51672-1254?
Patent expiration is projected for [specific date, e.g., 2025], after which biosimilar competition is anticipated to exert downward pressure on prices.
2. How will biosimilar entry impact the price of NDC 51672-1254?
Biosimilar entry typically leads to price reductions of 15-30%, dependent on market acceptance, regulatory landscape, and payer negotiations.
3. Are there upcoming regulatory approvals that could influence this drug's market?
Potential supplemental indications or new formulations under review could expand market size and justify higher pricing, though approval timelines vary.
4. What strategies can manufacturers employ to maintain profitability post-patent expiry?
Lifecycle management, such as developing improved formulations, expanding indications, and engaging in value-based pricing agreements, can help sustain margins.
5. How do reimbursement policies affect the drug's pricing prospects?
Reimbursements aligned with clinical value and negotiated discounts influence achievable pricing levels and market penetration.
Sources
- FDA approval documents for [drug name].
- World Health Organization. Global prevalence estimates of [condition].
- IMS Health Reports on pharmaceutical sales and market share.
- Deloitte Pharmaceutical Sector Insights, 2022.
More… ↓
